Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 3,808 shares at $48.06 ($183K) on 2025-10-02, disclosed to the SEC on 2025-10-03.
Scheduled sale ($183k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.06 | 1,904 | $92K | 50.0% |
| 2 | $48.06 | 1,904 | $92K | 50.0% |
| Total | $48.06 avg | 3,808 | $183K | 100% |
| Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |
| SUPN | SELL | 2025-09-30 | $983K | — | Filing → |